
WALD Stock Forecast & Price Target
WALD Analyst Ratings
Bulls say
Waldencast is a promising investment due to its strong revenue growth, especially in its Obagi Skincare segment which continues to outperform expectations and expand into new markets such as dermal fillers. While there are risks in the consumer-focused sector, Waldencast has a diversified product line and a solid online presence, making it well-equipped to handle potential challenges. With a positive outlook from management and the potential for continued growth, Waldencast is positioned for long-term success in the beauty and wellness industry.
Bears say
Waldencast is facing challenges with slower than expected growth, margin pressures, and risks associated with marketing a new product line for their Obagi Skincare segment. Additionally, the company's Milk Makeup segment has been impacted by softer international demand and is undergoing reorganization efforts. Following lower than expected results and reduced estimates, the company's price target has been lowered to $2 and they are currently undergoing a strategic review to maximize shareholder value.
This aggregate rating is based on analysts' research of Waldencast Acquisition Corp and is not a guaranteed prediction by Public.com or investment advice.
WALD Analyst Forecast & Price Prediction
Start investing in WALD
Order type
Buy in
Order amount
Est. shares
0 shares